NAGE

Niagen Bioscience

75 hedge funds and large institutions have $25.3M invested in Niagen Bioscience in 2022 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 21 increasing their positions, 25 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more funds holding in top 10

Funds holding in top 10:

less ownership

Funds ownership:

less funds holding

Funds holding:

less call options, than puts

Call options by funds: $ | Put options by funds: $

16% less repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 25

21% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 19

49% less capital invested

Capital invested by funds: $49.9M → $25.3M (-$24.6M)

Holders
75
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$100K
Puts
$117K
Net Calls
Net Calls Change

Top Buyers

1 +$1.43M
2 +$1.27M
3 +$534K
4
Citadel Advisors
Citadel Advisors
Florida
+$441K
5
E
Ergoteles
New York
+$385K

Top Sellers

1 -$3.62M
2 -$2.28M
3 -$1.88M
4
Bank of America
Bank of America
North Carolina
-$1.27M
5
State Street
State Street
Massachusetts
-$1.16M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$4.53M
2
$3.82M
3
$3.65M
4
$2.17M
5
$1.65M
6
$1.27M
7
$1.24M
8
$916K
9
$623K
10
$540K
11
$491K
12
$402K
13
$396K
14
$389K
15
$385K
16
$287K
17
$259K
18
$153K
19
$151K
20
$145K
21
$112K
22
$106K
23
$87K
24
$83K
25
$76K